AKT1 and breast carcinoma: In addition to promoting cancer cell metastasis through EMT, leptin can also promote the expression of lysine hydroxylase-2 (PLOD2) by activating the PI3K/AKT signaling pathway, thus promoting the metastasis of breast cancer (27).